glp 1 pharma companies A $60 billion industry just found its next growth lever. π With the expiry of a key patent on March 20, 2026, Indian majors are launching generic weight-loss and diabetes drugs leading pharmaceutical glp-1 treatments 2025Γ’β¬β’s
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 6 - Sep 11






















